The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 2.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ICICI Prudential Mutual Fund has sold 5,40,642 shares of Windlas Biotech Ltd through open market transactions between July 30, 2024 and May 13, 2026. The sale on May 13, 2026 alone was 1,44,516 shares, which triggered the 2% disclosure threshold. As a result, the fund's holding dropped from 14,53,777 shares (6.96%) to 9,13,135 shares (4.33%) of the company's paid-up capital. The mutual fund clarified that these are purely investment decisions and not aimed at gaining control of the company. This is not a promoter transaction.
A significant reduction in institutional holding from ~7% to ~4.3% could signal lack of confidence by a major institutional investor. While the fund explicitly denies any intention to seek control, the substantial reduction may raise concerns among retail shareholders about the company's near-term prospects.